Our main goal is providing quality effective medical products and taking care of patient safety!

Using medicinal products involves a therapeutic effect in accordance with the known pharmacological properties of the components that make up their composition. But at the same time, undesirable reactionsAdverse reaction - any unintended and noxious response to a medicinal product;may occur due to the peculiarities of the human organism's response or the properties of the components. 

Continuous monitoring throughout the life cycle of the medicinal product and timely detection of adverse reactions are of key importance for benefit/risk ratioBenefit-risk balance of medicinal product – an assessment of positive therapeutic effects of medicinal product against any risks relating to the quality, safety or efficacy of medicinal product as regards patients’ health or public health; assessment and maintaining a balance where the benefitBenefit – a range of degrees of positive effect of a medicinal product on a reduction of severity of the disease course or symptom manifestations, and an intensity of positive pharmacological response to medicinal product administration and its duration. overbalance under potential risks of using medicinal productsRisk related to the use of the medicinal product,– any risk related to the quality, safety or efficacy of medicinal product, as regards patients’ health or public health, or any risk of undesirable environmental effects;.

In terms of monitoring the safety of medicinal products, KONARK INTELMED has a pharmacovigilance systemPharmacovigilance system – a system used by a state or an applicant in order to monitor safety medicinal products, to complete the tasks and responsibilities of pharmacovigilance, and detect any changes in benefit-risk balance;in the company, which is created in accordance with international standards and requirements of Ukrainian legislation.

By reporting the adverse reactions of medicinal products monitored for pharmacovigilancePharmacovigilance – activities relating to the detection, collection, assessment, study and prevention of adverse reactions, or any other problems related safety and efficacy to the use of medicinal products; by KONARK INTELMED, you help us to monitor the safety profileSafety profile – a set of indices of use of medicinal product that allow a determination of a benefit-risk balance of the medicinal product; of our products and take the necessary measures to prevent the occurrence of adverse reactions in the future.

We will appreciate any information about adverse reaction, lack of efficacyLack of medicinal product’s efficacy – a lack of favorable diagnostic, therapeutic or preventive effect of a medicinal product on determination of the nature of a disease, its course and duration or correction of organism’s state or physiological functions according to the indications for use given in instructions for medical use.or any safety and efficacy information of the medicinal products, related or unrelated with the adverse reaction, i.e:

• undesirable reactions, which occurred during the use of the company's medicines;
• lack of efficacy;;
• off-label using;
• overdose or misuse;
• interaction with other medicines;
  
• incorrect prescription and using;
• inappropriate use of the medicinal product
• using during pregnancy and lactation;
• effect of the medicinal product on reproductive function;
• using medicinal product in special patient groups (children, elderly patients, etc.);
• unexpected therapeutic effect;
• unwanted effects of medicinal products during the professional activities;
• risks related to the utilization of the medicinal product;
• complaints about the quality of medicinal products that caused an adverse reaction;

If you have information about adverse reactions, lack of efficacy or other safety issues associated with the use of our medicinal products, for which pharmacovigilance is provided by КONARK INTELMED, you can contact us in any convenient way:
via patient/ healthcare professional ADR Form on our website;
via e-mail: pharmacovigilance@konark.com.ua
via phone:

              Тел: +38 044 502 63 91
              mob. phone. +38 050 327 39 25 (24/7)

The report should contain at least the following information:

• the tradename of the suspected medicinal product;
• description of the adverse reaction and / or a lack of efficacy indication;
• information about the patient who experienced an adverse reaction (full name (initials), age, gender or other important information);
• contact details and information about the person providing the report: full name, phone number, indicate - doctor, patient or representative of the patient (you should to write your contact information to receive additional information or provide you with a response, if necessary).

The information provided remains confidential and is not subject to disclosure, except as required by law.
You confirm your consent to the processing of personal data pressing "Submit".